| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |